Recombinant methionyl human stem cell factor (r-methuscf)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
60Aplastic anemia1

60. Aplastic anemia    [ 218 clinical trials,   362 drugs,   (DrugBank: 81 drugs),   39 drug target genes,   155 drug target pathways]
Searched query = "Aplastic anemia"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 218 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00001398
(ClinicalTrials.gov)
October 19933/11/1999Stem Cell Factor Medication for Aplastic AnemiaA Phase I/II Trial of Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF) in Patients Diagnosed With Acquired Aplastic AnemiaAplastic Anemia;PancytopeniaDrug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)National Heart, Lung, and Blood Institute (NHLBI)NULLCompletedN/AN/ABoth40Phase 1United States